Levobens (Benserazide, Levodopa)

Levodopa is a dopamine precursor that crosses the blood‑brain barrier and is converted into dopamine, directly replenishing the neurotransmitter that is deficient in Parkinsonian disorders. This conversion improves motor control and reduces characteristic symptoms.

The dose of Levobens is individualized by the prescribing clinician based on disease severity, patient response, and tolerability. The prescriber determines the appropriate strength, frequency, and titration schedule for each patient.

The safety of Levobens in pregnancy and lactation has not been established. It should only be used if the potential benefit justifies the potential risk to the fetus or infant, and this decision must be made by a qualified healthcare professional.

To order Levobens, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Levobens combines levodopa with benserazide, offering higher central dopamine availability than levodopa alone and fewer peripheral side effects. Compared with dopamine agonists, it provides more potent symptom control but may have a higher risk of motor complications such as dyskinesia.

Levobens should be stored at temperatures below 25 °C, in its original packaging, and protected from moisture and direct sunlight. Maintaining these conditions helps preserve tablet integrity and potency throughout its shelf life.

Levobens is taken orally, usually with a glass of water. It may be administered with or without food, but high‑protein meals can affect absorption, so consistent timing relative to meals is often recommended by the prescriber.

Serious risks include severe hypotension, hallucinations, neuroleptic malignant syndrome, and disabling dyskinesia. Patients should be monitored closely for these events, and any sudden changes in blood pressure, mental status, or movement patterns should prompt immediate medical evaluation.

Levobens is contraindicated in patients with known hypersensitivity to levodopa, benserazide, or any excipients. It should also be avoided in individuals taking non‑selective MAO inhibitors or those with narrow‑angle glaucoma, as it may exacerbate the condition.